JP2014510746A5 - - Google Patents

Download PDF

Info

Publication number
JP2014510746A5
JP2014510746A5 JP2014501719A JP2014501719A JP2014510746A5 JP 2014510746 A5 JP2014510746 A5 JP 2014510746A5 JP 2014501719 A JP2014501719 A JP 2014501719A JP 2014501719 A JP2014501719 A JP 2014501719A JP 2014510746 A5 JP2014510746 A5 JP 2014510746A5
Authority
JP
Japan
Prior art keywords
compound
formula
compound according
pharmaceutical composition
hcv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014501719A
Other languages
English (en)
Japanese (ja)
Other versions
JP6118792B2 (ja
JP2014510746A (ja
Filing date
Publication date
Priority claimed from GBGB1105293.3A external-priority patent/GB201105293D0/en
Priority claimed from GBGB1113629.8A external-priority patent/GB201113629D0/en
Priority claimed from GBGB1202060.8A external-priority patent/GB201202060D0/en
Application filed filed Critical
Priority claimed from PCT/GB2012/050700 external-priority patent/WO2012131371A1/en
Publication of JP2014510746A publication Critical patent/JP2014510746A/ja
Publication of JP2014510746A5 publication Critical patent/JP2014510746A5/ja
Application granted granted Critical
Publication of JP6118792B2 publication Critical patent/JP6118792B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014501719A 2011-03-29 2012-03-29 マクロ環状化合物及びその製造方法 Expired - Fee Related JP6118792B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB1105293.3 2011-03-29
GBGB1105293.3A GB201105293D0 (en) 2011-03-29 2011-03-29 Novel compounds and methods for their production
GBGB1113629.8A GB201113629D0 (en) 2011-08-08 2011-08-08 Novel compounds and methods for their production
GB1113629.8 2011-08-08
GB1202060.8 2012-02-07
GBGB1202060.8A GB201202060D0 (en) 2012-02-07 2012-02-07 Novel compounds and methods for their production
PCT/GB2012/050700 WO2012131371A1 (en) 2011-03-29 2012-03-29 Macrocyclic compound and methods for its production

Publications (3)

Publication Number Publication Date
JP2014510746A JP2014510746A (ja) 2014-05-01
JP2014510746A5 true JP2014510746A5 (enExample) 2015-05-14
JP6118792B2 JP6118792B2 (ja) 2017-04-26

Family

ID=46001313

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014501720A Active JP6118793B2 (ja) 2011-03-29 2012-03-29 マクロ環状化合物及びそれらの製造方法
JP2014501719A Expired - Fee Related JP6118792B2 (ja) 2011-03-29 2012-03-29 マクロ環状化合物及びその製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014501720A Active JP6118793B2 (ja) 2011-03-29 2012-03-29 マクロ環状化合物及びそれらの製造方法

Country Status (29)

Country Link
US (2) US9139613B2 (enExample)
EP (2) EP2691413B1 (enExample)
JP (2) JP6118793B2 (enExample)
KR (2) KR101911484B1 (enExample)
CN (3) CN107417766A (enExample)
AR (1) AR085724A1 (enExample)
AU (2) AU2012235880B2 (enExample)
BR (2) BR112013024974A2 (enExample)
CA (2) CA2830827C (enExample)
CL (2) CL2013002740A1 (enExample)
CY (2) CY1116318T1 (enExample)
DK (2) DK2691412T3 (enExample)
EA (2) EA023848B1 (enExample)
ES (2) ES2533438T3 (enExample)
HR (2) HRP20150184T1 (enExample)
IL (2) IL228508B (enExample)
JO (1) JO3063B1 (enExample)
MX (2) MX345351B (enExample)
MY (2) MY170618A (enExample)
PH (2) PH12013502016A1 (enExample)
PL (2) PL2691412T3 (enExample)
PT (2) PT2691413E (enExample)
RS (2) RS53964B1 (enExample)
SG (2) SG193568A1 (enExample)
SI (2) SI2691413T1 (enExample)
TW (1) TWI525098B (enExample)
UY (1) UY33993A (enExample)
WO (2) WO2012131371A1 (enExample)
ZA (2) ZA201307149B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012019866A8 (pt) 2010-02-09 2017-12-26 Biotica Tech Limited Composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto
JO3063B1 (ar) * 2011-03-29 2017-03-15 Neurovive Pharmaceutical Ab مركب مبتكر وطرق لانتاجه
CN103130734A (zh) * 2011-12-01 2013-06-05 上海药明康德新药开发有限公司 一种合成1,2-吗啉盐酸盐的方法
CN105695541B (zh) * 2016-03-10 2019-03-15 苏州华赛生物工程技术有限公司 一种抗生素nvp018中间体的分离纯化方法
KR20180036522A (ko) 2016-09-30 2018-04-09 (주)나노믹스 스틸벤 유도체 및 그 제조 방법
MX2019005349A (es) * 2016-11-18 2019-08-05 Neurovive Pharmaceutical Ab Uso de analogos de sangliferina macrociclicos como compuestos anticancerigenos.
CN112410353B (zh) * 2019-08-23 2023-01-24 上海医药工业研究院 一种fkbS基因、含其的基因工程菌及其制备方法和用途
EP4054719B1 (en) 2019-11-04 2026-02-11 Revolution Medicines, Inc. Ras inhibitors
CR20230165A (es) 2020-09-15 2023-06-02 Revolution Medicines Inc Derivados indólicos como inhibidores de ras en el tratamiento del cáncer
CR20230558A (es) 2021-05-05 2024-01-24 Revolution Medicines Inc Inhibidores de ras para el tratamiento del cáncer
AR127308A1 (es) 2021-10-08 2024-01-10 Revolution Medicines Inc Inhibidores ras
CN115028681B (zh) * 2022-08-11 2022-11-15 中国科学院微生物研究所 一种降解亲环素a的嵌合体化合物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR006514A1 (es) 1995-07-04 1999-09-08 Sandoz Ag Un macrolido, sus usos, un proceso para producirlo, un aislado biologicamente puro capaz de producirlo, y una composicion farmaceutica quelo comprende
US6124453A (en) 1995-07-04 2000-09-26 Novartis Ag Macrolides
RU2427372C2 (ru) * 2005-06-17 2011-08-27 Новартис Аг Применение санглиферина для лечения вируса гепатита с
RU2462262C2 (ru) 2007-01-04 2012-09-27 Дебиофарм С А Неиммуносупрессорный циклоспорин для лечения врожденной миопатии ульриха
US8962329B2 (en) 2008-09-24 2015-02-24 Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences Gene cluster
CN101691575B (zh) * 2008-09-24 2013-06-05 中国科学院上海有机化学研究所 一种萨菲菌素的生物合成基因簇
WO2011098805A1 (en) * 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
WO2011098808A1 (en) * 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
BR112012019866A8 (pt) * 2010-02-09 2017-12-26 Biotica Tech Limited Composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto
KR101935213B1 (ko) * 2010-12-20 2019-01-03 뉴로바이브 파마슈티컬 에이비 상글리페린 유도체 및 이의 제조 방법
JO3063B1 (ar) * 2011-03-29 2017-03-15 Neurovive Pharmaceutical Ab مركب مبتكر وطرق لانتاجه

Similar Documents

Publication Publication Date Title
JP2014510746A5 (enExample)
EP3527573B9 (en) Synthesis of polycyclic-carbamoylpyridone compounds
JP2015536940A (ja) 抗ウイルス性ホスホネート類似体及びその製造方法
HRP20150184T1 (hr) Makrocikliäśki spoj i postupci za njegovu proizvodnju
EP2321323B9 (fr) Derives dimeriques d'artemisinine et application en therapie anticancereuse
Ye et al. Studies on the asymmetric synthesis of pandamarilactonines: an unexpected syn-selective vinylogous Mannich reaction of N-tert-butanesulfinimines
CN115135646B (zh) 取代的多环化合物及其药物组合物和用途
WO2009074020A1 (fr) Amides n-substitués par alpha-amino, composition pharmaceutique les contenant et leurs utilisations
JP2009143931A (ja) テトラゾリルベンゾピランの製法
JP2016503389A (ja) (1s,4s,5s)−4−ブロモ−6−オキサビシクロ[3.2.1]オクタン−7−オンの調製方法
CA2647163C (en) Modified macrophage migration inhibitory factor inhibitors
WO2016038560A1 (en) Process for the preparation of enzalutamide
RU2010134904A (ru) Кристаллическая форма абакавира, которая, по существу, свободна от растворителя
CN120424092B (zh) 布尼亚病毒抑制剂及其制备方法和用途
JP5863846B2 (ja) イリノテカンの製造方法
CN111417632A (zh) 噻唑-5-甲酸衍生物及其制备方法与应用
CN110590768B (zh) 杂环化合物、其组合物及其作为抗流感病毒药物的应用
WO2017009746A1 (en) An improved process for the preparation of sofosbuvir
Therkelsen et al. New emivirine (MKC-442) analogues containing a tetrahydronaphthalene at C-6 and their anti-HIV activity
HK40066086A (zh) 多环氨基甲醯基吡啶酮化合物的合成
CN120574228A (zh) 取代的多环吡啶酮类衍生物及其制备方法和用途
HK40044746A (en) Synthesis of polycyclic-carbamoylpyridone compounds
CZ2014792A3 (cs) Způsob přípravy, izolace a čištění farmaceuticky využitelných forem AHU-377
HK40011503A (en) Synthesis of polycyclic-carbamoylpyridone compounds
HK40011503B (en) Synthesis of polycyclic-carbamoylpyridone compounds